U.S. market Closed. Opens in 1 day 11 hours 13 minutes

EYPT | EyePoint Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-30
Revenue46.02M41.40M36.94M34.44M20.36M2.96M7.54M1.62M26.57M3.47M2.14M3.53M4.96M23.05M12.16M3.48M2.23M1.47M629.52K265.23K74.35K516.32K
Cost of Revenue4.63M8.33M8.18M5.82M2.69M18.50MN/A815.00K14.38M78.00K9.57M7.00M7.04MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit41.39M33.08M28.76M28.61M17.68M-15.54M7.54M805.00K12.18M3.40M-7.43M-3.48M-2.07M23.05M12.16M3.48M2.23M1.47M629.52K265.23K74.35K516.32K
Operating Expenses115.05M112.02M84.04M65.90M65.54M29.23M26.11M23.39M20.14M17.04M14.17M13.91M14.97M13.96M16.80M28.38M37.78M29.14M10.88M6.50M3.67M1.80M
Selling, General & Admin51.79M60.32M53.08M46.02M47.71M13.06M11.23M9.01M8.06M7.47M7.17M6.87M8.10M6.97M8.79M13.95M12.98M15.88M3.81M1.60M565.51KN/A
Research & Development64.66M49.64M28.50M17.42M15.37M16.18M14.88M14.38M12.09M9.57M7.00M7.04M6.86M6.99M8.01M14.43M20.03M11.70M6.29M4.87M3.08M1.80M
Other Operating ExpensesN/A2.05M2.46M2.46M2.46M14.84M8.31M13.98M3.00K7.26M6.22M19.79M3.25M3.25MN/A71.20M4.76M1.56M781.71K27.35K25.42KN/A
Operating Income-75.07M-78.94M-55.28M-37.29M-47.86M-26.27M-18.58M-21.77M6.42M-13.49M-12.03M-25.21M-10.00M9.09M-4.64M-24.90M-35.54M-27.68M-10.25M-6.24M-3.60M-1.80M
Other Expenses / Income4.36M-2.62M-3.14M-8.10M-8.93M-63.17M-26.90M91.00K72.00K22.00K5.00K14.00K207.00K1.16M-315.00K1.17M8.85M-61.21M-17.73M9.32M-807.00-1.80M
Before Tax Income-70.71M-102.25M-58.42M-45.39M-56.79M-53.17M-18.48M-21.70M6.44M-13.48M-12.02M-25.00M-8.85M8.78M-3.46M-76.15M-127.20M-27.98M-11.49M-5.22M-3.60M-2.25M
Income Tax Expenses83.00K22.26M5.50M7.26M6.18M-25.56M-815.00K-155.00K96.00K-130.00K-117.00K-169.00K-218.00K23.00K-951.00K-483.00K-23.53M-7.07M-303.15K-2.67M-1.74M-1.80M
Net Income-70.80M-124.51M-63.91M-52.65M-62.97M-53.17M-18.48M-21.55M6.35M-13.36M-11.90M-24.84M-8.63M8.75M-2.51M-75.67M-103.67M-20.91M-11.18M-2.56M-1.86M-2.25M
Interest Expenses1.25M3.19M5.50M7.26M6.18M720.00K720.00KN/AN/A1.00K2.00KN/A1.00K13.00KN/A507.00K1.94M3.37M3.37M3.92K3.92KN/A
Basic Shares Outstanding38.90M37.32M28.76M12.84M10.43M4.62M3.53M3.16M2.94M2.74M2.30M2.08M1.95M1.84M1.83M1.82M1.10M752.10K519.50K3.06M253.65K410.92K
Diluted Shares Outstanding38.90M37.32M28.76M12.84M10.43M4.62M3.53M3.16M3.06M2.74M2.30M2.08M1.95M1.89M1.83M1.82M1.10M752.10K519.50K1.23M253.65K410.92K
EBITDA-69.00M-96.62M-50.15M-35.49M-48.01M-36.99M-18.58M-17.67M-20.87M7.30M-12.65M-11.04M-22.78M-5.49M9.09M-24.00K-75.65M-22.05M-18.98M-9.44M-6.00M-3.39M
EBITDA Margin-149.94%-233.36%-135.76%-103.05%-235.76%-1,249.38%-246.40%-1,090.74%-78.55%210.28%-590.34%-313.02%-458.75%-23.82%74.75%-0.69%-3,384.61%-1,504.38%-3,014.50%-3,558.16%-8,063.89%-655.69%
EBIT-69.47M-99.06M-52.92M-38.14M-50.62M-78.01M-18.58M-21.70M6.44M-13.48M-12.02M-25.00M-8.85M8.79M-3.46M-75.65M-125.26M-24.61M-8.11M-5.22M-3.59M-4.05M
EBIT Margin-150.95%-239.26%-143.26%-110.74%-248.55%-2,634.55%-246.45%-1,339.63%24.25%-388.25%-560.66%-709.13%-178.15%38.13%-28.47%-2,176.24%-5,604.61%-1,679.23%-1,288.67%-1,968.50%-4,834.45%-783.75%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙